1. 1) Hora, M. Manufacturing fundamentals for biopharmaceuticals. in Formulation and process development strategies for manufacturing biopharmaceuticals (Jameel, F.; Hershenson, S. eds.) John Wiley & Sons, Inc., Chapter 24, pp. 589-604 (2010).
2. 2) Costantino, H. Excipients for use in lyophilized pharmaceutical peptide, protein, and other bioproducts. in Lyophilization of biopharmaceuticals (Biotechnology: Pharmaceutical Aspects series, Volume 2) (Costantino, H. R.; Pikal, M. J., eds.) American Association of Pharmaceutical Scientists. Arlington, VA, Chapter 5, pp. 139-226 (2004).
3. 3) Carpenter, J. F.; Izutsu, K. I.; Randolph, T. W. Freezing- and drying-induced perturbations of protein structure and mechanisms of protein protection by stabilizing additives. in Freeze drying/lyophilization of pharmaceutical and biological products, third edition. (Rey, L.; May, J. C., eds.), CRC Press, New York & London, Chapter 7, pp. 167-197 (2010).
4. 4) Jameel, F.; Pikal, M. J. Design of a formulation for freeze drying. in Formulation and process development strategies for manufacturing biopharmaceuticals (Jameel, F.; Hershenson, S. eds.) John Wiley & Sons, Inc., Chapter 18, pp. 459-492 (2010).
5. 5) Drummond, C. J.; Fong, C.; Krodkiewska, I.; Boyd, B. J.; Baker, I. J. A. Sugar Fatty Acid Esters. in Novel Surfactants, Preparation, Applications and Biodegradability (Holmberg, K. ed.) Surfactant science series 114, MarcelDekker, pp. 95-128 (2003).